Yabao Pharmaceutical Group Co., Ltd (600351.SS)

CNY 6.27

(-0.16%)

Total Liabilities Summary of Yabao Pharmaceutical Group Co., Ltd

  • Yabao Pharmaceutical Group Co., Ltd's latest annual total liabilities in 2023 was 860.33 Million CNY , down -23.49% from previous year.
  • Yabao Pharmaceutical Group Co., Ltd's latest quarterly total liabilities in 2024 Q1 was 865.7 Million CNY , up 0.63% from previous quarter.
  • Yabao Pharmaceutical Group Co., Ltd reported annual total liabilities of 1.12 Billion CNY in 2022, up 1.02% from previous year.
  • Yabao Pharmaceutical Group Co., Ltd reported annual total liabilities of 1.11 Billion CNY in 2021, down -6.93% from previous year.
  • Yabao Pharmaceutical Group Co., Ltd reported quarterly total liabilities of 865.7 Million CNY for 2024 Q1, up 0.63% from previous quarter.
  • Yabao Pharmaceutical Group Co., Ltd reported quarterly total liabilities of 708.41 Million CNY for 2024 Q3, down -13.83% from previous quarter.

Annual Total Liabilities Chart of Yabao Pharmaceutical Group Co., Ltd (2023 - 1999)

Historical Annual Total Liabilities of Yabao Pharmaceutical Group Co., Ltd (2023 - 1999)

Year Total Liabilities Total Liabilities Growth
2023 860.33 Million CNY -23.49%
2022 1.12 Billion CNY 1.02%
2021 1.11 Billion CNY -6.93%
2020 1.19 Billion CNY -24.7%
2019 1.58 Billion CNY -12.42%
2018 1.81 Billion CNY 24.71%
2017 1.45 Billion CNY -1.42%
2016 1.47 Billion CNY -6.27%
2015 1.57 Billion CNY 15.29%
2014 1.36 Billion CNY -9.36%
2013 1.5 Billion CNY 18.69%
2012 1.26 Billion CNY 14.16%
2011 1.11 Billion CNY -22.19%
2010 1.42 Billion CNY 8.99%
2009 1.31 Billion CNY 55.33%
2008 843.93 Million CNY 21.56%
2007 694.23 Million CNY 2.74%
2006 675.73 Million CNY -13.41%
2005 780.41 Million CNY 30.15%
2004 599.64 Million CNY 72.97%
2003 346.67 Million CNY 104.44%
2002 169.57 Million CNY -0.01%
2001 169.58 Million CNY 25.23%
2000 135.42 Million CNY 16.95%
1999 115.79 Million CNY 0.0%

Peer Total Liabilities Comparison of Yabao Pharmaceutical Group Co., Ltd

Name Total Liabilities Total Liabilities Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 4.7 Billion CNY 81.705%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 40.9 Billion CNY 97.897%
Harbin Pharmaceutical Group Co., Ltd. 8.37 Billion CNY 89.722%
Tasly Pharmaceutical Group Co., Ltd 3.86 Billion CNY 77.742%
Zhejiang Medicine Co., Ltd. 2.79 Billion CNY 69.199%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 3.49 Billion CNY 75.364%
Lionco Pharmaceutical Group Co.,Ltd. 693.51 Million CNY -24.053%
Humanwell Healthcare (Group) Co.,Ltd. 15.38 Billion CNY 94.409%
Ginwa Enterprise (Group) Inc. 470.12 Million CNY -83.001%
Joincare Pharmaceutical Group Industry Co.,Ltd. 13.34 Billion CNY 93.555%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 440.92 Million CNY -95.121%
China Animal Husbandry Industry Co., Ltd. 2.38 Billion CNY 63.904%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 299.24 Million CNY -187.496%
Zhejiang Huahai Pharmaceutical Co., Ltd. 10.34 Billion CNY 91.687%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.6 Billion CNY 46.364%
Ningbo Menovo Pharmaceutical Co., Ltd. 2.23 Billion CNY 61.555%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 2.2 Billion CNY 61.067%
Chongqing Taiji Industry(Group) Co.,Ltd 10.52 Billion CNY 91.827%
HPGC Renmintongtai Pharmaceutical Corporation 4.55 Billion CNY 81.109%
Nanjing Well Pharmaceutical Group Co.,Ltd. 686.22 Million CNY -25.372%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 2.24 Billion CNY 61.664%
Henan Lingrui Pharmaceutical Co., Ltd. 1.97 Billion CNY 56.4%
Shenzhen Chipscreen Biosciences Co., Ltd. 1.54 Billion CNY 44.137%
Guizhou Yibai Pharmaceutical Co., Ltd. 1.47 Billion CNY 41.581%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 1.6 Billion CNY 46.52%
Zhongzhu Healthcare Holding Co.,Ltd 422.34 Million CNY -103.705%
Beijing Tongrentang Co., Ltd 9.67 Billion CNY 91.107%
KPC Pharmaceuticals, Inc. 3.9 Billion CNY 77.97%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 515.97 Million CNY -66.74%
North China Pharmaceutical Company Ltd. 14.68 Billion CNY 94.142%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 3.52 Billion CNY 75.601%
Tibet Weixinkang Medicine Co., Ltd. 436.54 Million CNY -97.076%
China National Medicines Corporation Ltd. 14.87 Billion CNY 94.216%
Zhejiang Hisun Pharmaceutical Co., Ltd. 9.26 Billion CNY 90.713%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 4.42 Billion CNY 80.558%
ChengDu ShengNuo Biotec Co.,Ltd. 431.06 Million CNY -99.581%
Dali Pharmaceuticalco.,Ltd 92.7 Million CNY -827.992%
Changchun BCHT Biotechnology Co. 1.01 Billion CNY 15.323%
Zhejiang Shengda Bio-Pharm Co., Ltd. 449.19 Million CNY -91.527%
Shanghai Jiaoda Onlly Co.,Ltd 475.91 Million CNY -80.774%
Jiang Zhong Pharmaceutical Co.,Ltd 1.6 Billion CNY 46.38%
Mayinglong Pharmaceutical Group Co., LTD. 959.61 Million CNY 10.347%
Cisen Pharmaceutical Co., Ltd. 1.57 Billion CNY 45.25%
Hunan Warrant Pharmaceutical Co.,Ltd 358.76 Million CNY -139.803%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 56.77 Billion CNY 98.485%
Jianmin Pharmaceutical Group Co.,Ltd. 1.89 Billion CNY 54.549%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.49 Billion CNY 42.347%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.38 Billion CNY 74.615%
Guobang Pharma Ltd. 2.92 Billion CNY 70.581%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 1.03 Billion CNY 16.619%
Kangmei Pharmaceutical Co., Ltd. 7.19 Billion CNY 88.051%
Shandong Buchang Pharmaceuticals Co., Ltd. 9.2 Billion CNY 90.653%
Zhejiang Starry Pharmaceutical Co.,Ltd. 3.66 Billion CNY 76.547%
Henan Taloph Pharmaceutical Stock Co.,Ltd 1.95 Billion CNY 55.885%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 1.65 Billion CNY 47.863%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.64 Billion CNY 76.424%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 805.75 Million CNY -6.773%
Shanghai Shyndec Pharmaceutical Co., Ltd. 4.89 Billion CNY 82.411%
Shanghai Yizhong Pharmaceutical Co., Ltd. 107.05 Million CNY -703.648%
Tibet Rhodiola Pharmaceutical Holding Co. 1.18 Billion CNY 27.574%
Sichuan Huiyu Pharmaceutical Co., Ltd. 886.91 Million CNY 2.998%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 696.15 Million CNY -23.583%
CanSino Biologics Inc. 3.86 Billion CNY 77.743%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 1.33 Billion CNY 35.719%
Shandong Lukang Pharmaceutical Co.,Ltd. 4.95 Billion CNY 82.62%